Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

730
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
730
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

495
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
495
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

808
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
808
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

427
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
427
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

1.3K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.3K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

1.0K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sharing of prescription analgesics amongst patients in family practice: Frequency and associated factors.

European journal of pain (London, England)·2017
Same author

[RESISTANT ARTERIAL HYPERTENSION – APPROACH TO PATIENT IN FAMILY MEDICINE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same author

[APPROACH TO A PATIENT WITH DYSPEPSIA IN FAMILY MEDICINE PRACTICE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same author

[GASTROESOPHAGEAL REFLUX DISEASE – A MULTIFACETED DISEASE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same author

[PATIENT WITH PEPTIC ULCER DISEASE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same author

[NON-ALCOHOLIC FATTY LIVER DISEASE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[CHARACTERISTIC FEATURES OF PRESSURE ULCER INFECTION].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[PERSONALIZED APPROACH TO PATIENT WITH CHRONIC WOUND IN FAMILY MEDICINE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[APPLICATION OF TOPICAL HEMOGLOBIN SPRAY IN INFECTED POSTTRAUMATIC AND POSTOPERATIVE WOUNDS].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[APPLICATION OF NEGATIVE PRESSURE THERAPY].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[PATIENTS WITH PRESSURE ULCERS IN THE UNIFIED EMERGENCY ADMISSION DEPARTMENT – OUR REALITY].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[Proposition of algorhythm for treatment with hyperbaric oxygenation Hyperbaric oxygenation in Rijeka Clinical Hospital Center].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
See all related articles

Related Experiment Video

Updated: Feb 19, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.8K

[ANEMIA IN CHRONIC KIDNEY DISEASE].

L Bukmir, M Fišić, I Diminić-Lisica

    Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti
    |November 1, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Anemia in chronic kidney disease (CKD) requires early recognition and treatment with erythropoiesis-stimulating agents (ESA). Individualized hemoglobin targets improve quality of life and reduce risks for CKD patients.

    More Related Videos

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
    05:34

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

    Published on: April 4, 2025

    1.8K
    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
    07:52

    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

    Published on: November 7, 2017

    22.2K

    Related Experiment Videos

    Last Updated: Feb 19, 2026

    Assessment of Vascular Function in Patients With Chronic Kidney Disease
    08:50

    Assessment of Vascular Function in Patients With Chronic Kidney Disease

    Published on: June 16, 2014

    16.8K
    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
    05:34

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

    Published on: April 4, 2025

    1.8K
    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
    07:52

    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

    Published on: November 7, 2017

    22.2K

    Area of Science:

    • Nephrology
    • Hematology
    • Primary Care Medicine

    Background:

    • Renal anemia is a common complication of chronic kidney disease (CKD), increasing with disease severity.
    • Effective management of renal anemia is crucial for patient outcomes and quality of life.

    Purpose of the Study:

    • To update family physicians on current approaches to renal anemia management in CKD.
    • To provide guidance aligned with national guidelines for primary healthcare providers.

    Main Methods:

    • Systematic literature search of PubMed and Cochrane databases (1996-2015).
    • Keywords included: anemia, chronic renal failure, erythropoietin, primary health care.
    • Manual search of relevant articles and textbooks.

    Main Results:

    • Erythropoiesis-stimulating agents (ESA) can slow CKD progression, decrease transfusion needs, and enhance patient quality of life.
    • Recommended target hemoglobin (Hb) is 110-120 g/L, with higher levels linked to increased mortality and cardiovascular events in dialysis patients.
    • Individualized Hb targets are essential, considering CKD stage, age, and patient-specific factors.

    Conclusions:

    • Early detection and treatment of anemia in CKD patients using ESA are critically important.
    • Systematic prevention strategies and adherence to national guidelines by family practitioners can optimize CKD patient care.
    • Personalized treatment approaches are key to managing renal anemia effectively.